| |
|
|
| |
EVENT DETAILS |
The New Jersey Innovation Institute, the University of Cologne, and German Center for Research and Innovation cordially invite you to a panel discussion on Applications of CRISPR Technologies in Research and Industry on Thursday, March 30, 2017.
Few discoveries have attracted more attention in the area of molecular biology over the last three years than CRISPR-Cas9. Our panelists will address a number of the applications of this cutting-edge technology and discuss some of its challenges.
Speakers:
Dr. Paul Bernasconi
Director, Molecular Biology Manager for RTP Plant Science Research Site, BASF
Prof. Dr. Branko Zevnik
Head of in vivo Research Facility, CECAD Cologne
Dr. Ghassan Yehia
Scientific Director, Genome Editing Core Facility
Rutgers, the State University of New Jersey
Moderator:
Dr. Benedikt Bosbach
Researcher, Oncology Target Discovery Program, Pfizer
Located in the German House, 871 United Nations Plaza (First Ave. at 49th Street), New York, NY
|
|
|
|
|
|
